TY - JOUR T1 - Cyclosporine A and amlodipine induced gingival overgrowth in a kidney transplant recipient: case presentation with literature review JF - BMJ Case Reports JO - BMJ Case Reports DO - 10.1136/bcr-2019-229587 VL - 12 IS - 5 SP - e229587 AU - Tarun Nanda AU - Baljeet Singh AU - Parul Sharma AU - Karandeep Singh Arora Y1 - 2019/05/01 UR - http://casereports.bmj.com/content/12/5/e229587.abstract N2 - Drug-induced gingival overgrowth is a condition caused by side effects of treatment with one of three types of drugs: phenytoin (used in epilepsy treatment), cyclosporine A (used in transplantology after allogenic organ transplants) and calcium channel blockers (used in the treatment of hypertension). Gingival overgrowth leads to inflammation within the gums and periodontium and can amplify the existing periodontal disease leading to tooth loss. Patients who have undergone kidney transplant are given immunosuppressants to prevent transplant rejection and mostly it is accompanied with calcium channel blockers to treat hypertension associated with kidney transplant. This article reports a case of recent gingival enlargement associated with cyclosporine A and amlodipine given to a kidney transplant patient from the past 11 years. ER -